Johnson & Johnson: Quality, But It Doesn't Deserve A Mid-20s Multiple Right Now

JNJ stock is up 28% YTD, beating SPY/XLV, but a premium valuation may cap upside.

Summarised by Agaah from Seeking Alpha. Agaah aggregates 36 sources and removes duplicate coverage — all news, one place.